Cargando…

Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort Study

BACKGROUND: The prognosis of non-small cell lung cancer (NSCLC) patients with central nervous system (CNS) metastasis is poor. The treatment for CNS metastasis could prolong the overall survival of NSCLC patients. We aimed to investigate the prognostic factors of Chinese NSCLC patients with CNS meta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xiaoxing, Chen, Minjiang, Liu, Xiaoyan, Shi, Yuequan, Liang, Hongge, Zhou, Qing, Zhao, Jing, Pan, Ruili, Zhong, Wei, Xu, Yan, Wang, Mengzhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090435/ https://www.ncbi.nlm.nih.gov/pubmed/35558520 http://dx.doi.org/10.3389/fonc.2022.879554

Ejemplares similares

Clinicopathological characteristics of lung cancer in patients with systemic sclerosis
por: Chen, Minjiang, et al.
Publicado: (2020)

Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis
por: Gao, Xiaoxing, et al.
Publicado: (2022)

Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis
por: Xu, Yan, et al.
Publicado: (2022)

Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China
por: Miao, Kang, et al.
Publicado: (2022)

Editorial: Mechanisms and Therapy for Cancer Metastasis to the Central Nervous System
por: Zhao, Haotian, et al.
Publicado: (2019)

Study protocol of KeyPemls‐004: A phase 2 study of pembrolizumab in combination with plinabulin and docetaxel in previously treated patients with metastatic non‐small cell lung cancer and progressive disease (PD) after immunotherapy (PD‐1/PD‐L1 inhibitor) alone or in combination with platinum‐doublet chemotherapy
por: Liu, Jia, et al.
Publicado: (2023)

Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System
por: Singh, Mohini, et al.
Publicado: (2017)

Clinical and pathological factors and outcome of central nervous system metastasis in breast cancer
por: Dettwiler, Dimitri, et al.
Publicado: (2023)

Circulating tumor cells PD‐L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non‐small‐cell lung cancer
por: Zhou, Qing, et al.
Publicado: (2023)

Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases
por: Ye, Qiuyue, et al.
Publicado: (2023)

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer
por: Liang, Hongge, et al.
Publicado: (2022)

Prognostic impact of maximum standardized uptake value on (18)F‐FDG PET/CT imaging of the primary lung lesion on survival in advanced non‐small cell lung cancer: A retrospective study
por: Qiu, Xiaoling, et al.
Publicado: (2021)

Isolated central nervous system metastasis in pediatric Wilms' tumor: A case report and review of literature
por: Borni, Mehdi, et al.
Publicado: (2018)

Patterns of response in metastatic NSCLC during PD‐1 or PD‐L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria
por: Liang, Hongge, et al.
Publicado: (2020)

Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma
por: Ma'koseh, Mohammad, et al.
Publicado: (2021)

Rosai–Dorfman disease of the central nervous system: A clinical, radiological, and prognostic study of 12 cases
por: Zhang, Xingshu, et al.
Publicado: (2022)

Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib
por: Liang, Hongge, et al.
Publicado: (2019)

Risk factors for immune-related adverse events: what have we learned and what lies ahead?
por: Liu, Xiaoyan, et al.
Publicado: (2021)

Circulating cytokines associated with clinical outcomes in advanced non‐small cell lung cancer patients who received chemoimmunotherapy
por: Shi, Yuequan, et al.
Publicado: (2021)

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus
por: Liu, Jia, et al.
Publicado: (2022)

Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC
por: Zhang, Haoran, et al.
Publicado: (2023)

Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis
por: Cai, Huarong, et al.
Publicado: (2020)

Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer
por: Si, Xiaoyan, et al.
Publicado: (2020)

Prognostic features of endometrial cancer metastasis to the central nervous system
por: Kuznicki, Michelle L., et al.
Publicado: (2022)

Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis
por: Peng, Honghua, et al.
Publicado: (2021)

An unusual case of high grade papillary urothelial carcinoma of renal pelvis revealed by a solitary central nervous system metastasis
por: Mehdi, Borni, et al.
Publicado: (2018)

Advances in Lung Cancer Driver Genes Associated With Brain Metastasis
por: Kang, Yalin, et al.
Publicado: (2021)

Sarcoidosis‐like reaction after neoadjuvant pembrolizumab combined with chemotherapy mimicking disease progression of NSCLC induced encouraging discovery of pathological complete response
por: Shi, Yuequan, et al.
Publicado: (2021)

Incidence, Prognostic Factors and Survival for Hemangioblastoma of the Central Nervous System: Analysis Based on the Surveillance, Epidemiology, and End Results Database
por: Yin, Xiangdong, et al.
Publicado: (2020)

Epidemiologic Characteristics, Prognostic Factors, and Treatment Outcomes in Primary Central Nervous System Lymphoma: A SEER-Based Study
por: Tang, Dongsheng, et al.
Publicado: (2022)

Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment
por: Liang, Hongge, et al.
Publicado: (2018)

A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis and Primary Central Nervous System Lymphoma: A Pilot Study
por: Tariciotti, Leonardo, et al.
Publicado: (2022)

BRAF Alteration in Central and Peripheral Nervous System Tumors
por: Srinivasa, Komal, et al.
Publicado: (2020)

Primary Central Nervous System Lymphoma With Systemic Recurrence
por: Pandravada, Sasirekha, et al.
Publicado: (2021)

Pathogenesis of central nervous system germ cell tumors
por: Liu, Siyuan, et al.
Publicado: (2022)

Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy
por: Luo, Qian, et al.
Publicado: (2021)

Prognostic Score for De Novo Metastatic Breast Cancer With Liver Metastasis and Its Predictive Value of Locoregional Treatment Benefit
por: Ji, Lei, et al.
Publicado: (2021)

Isolated Central Nervous System Metastasis From Neuroendocrine Carcinoma of the Cervix Without Pulmonary Metastasis
por: Valenzuela, Fabiola, et al.
Publicado: (2020)

The Antitumor Effect of Gene-Engineered Exosomes in the Treatment of Brain Metastasis of Breast Cancer
por: Liu, Minchen, et al.
Publicado: (2020)

Prognosticators and Prognostic Nomograms for Leiomyosarcoma Patients With Metastasis
por: Zou, YuChi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i8g6b6v40et6cib8r258v01i1q